|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Welcome Welcome to EUSA Pharma EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company’s name suggests). EUSA Pharma has grown rapidly since its formation in 2006, and now incorporates Talisker Pharmaceuticals, which it acquired in July 2006, OPi, purchased in March 2007, the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc, acquired in August 2007, and Cytogen, which EUSA purchased in May 2008.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Last Updated: 26th Jan 2010
| Back to home page | Legal | Privacy Policy |
